Chronic Kidney Disease News

Survivors of childhood cancer are more likely to have prediabetes at younger ages than the general public, increasing their already elevated risk for diabetes and cardiovascular and kidney diseases, study findings showed.

In clinical trials, sparsentan proved more effective in reducing proteinuria vs. irbesartan in adults with focal segmental glomerulosclerosis, but there was no major change in GFR among patients on the two drugs, a study found.

Health Canada has approved the use of Jardiance for the treatment of adults with chronic kidney disease, according to a press release.

Monitoring nutritional status is not the same for pediatric and adult patients with chronic kidney disease, and all nephrologists should be aware of the differences, according to an article in Seminars in Nephrology.

A higher frequency of adding salt to food may be associated with an increased risk of chronic kidney disease in the general population, according to a recently published study.

Patients who are on dialysis consider polypharmacy as “a necessary evil,” even when they do not notice positive effects, according to results of a study published in Kidney Medicine.

More older patients with COPD, dementia or kidney failure had a palliative care consultation shortly after admission through a default ordering system vs. usual care, according to study results published in JAMA.

The FDA has added a boxed warning for denosumab to advise patients with advanced chronic kidney disease of an increased risk for severe hypocalcemia, according to an FDA drug safety communication.

An accelerated hepatitis B virus vaccine regimen may be effective in reaching rapid seroconversion for adults with advanced chronic kidney disease, according to a study.

Intradialytic hypotension and mortality in adolescents and young adults with kidney failure requiring hemodialysis share no significant connection, a recently published study found.